Evelo Biosciences Inc. (EVLO)

AI Score

Unlock

0.00

-0.00 (-100.00%)

At close: Apr 03, 2025, 11:37 AM

Evelo Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q1 2017
Period Ending	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Mar 31, 2017
Cash & Equivalents	17.26M	7.62M	27.47M	47.94M	69.05M	92.01M	39.63M	68.44M	95.94M	123.33M	124.59M	68.86M	81.58M	90.17M	58.12M	77.83M	97.06M	113.47M	129.44M	147.92M	79.71M	178.9M	114.31M	38.25M	-15.54K
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	4M	23.95M	54.82M	84.61M	n/a	n/a	n/a	31.07K
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	797K	1.42M	1.16M	1.16M	1.16M	1.16M	1.16M	1.31M	1.39M	1.31M	1.31M	3.55M	1.5M	1.57M	1.57M	4.75M	1.57M	5.25M	5.16M	5.02M	1.5M	1.5M	2.7M	1.51M	n/a
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	7.5M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	1.67M	3.64M	2.61M	3.63M	n/a	5M	3.49M	n/a	n/a	n/a	n/a	2.12M	n/a	n/a	2.88M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	18.94M	11.26M	30.08M	51.57M	72.33M	97.01M	43.13M	71.03M	97.92M	126.37M	134.18M	68.86M	84.56M	92.72M	60.99M	77.83M	101.23M	113.47M	129.44M	147.92M	168.04M	180.88M	115.19M	38.78M	15.54K
Property-Plant & Equipment	894K	8.13M	10.73M	11.71M	12.85M	13.74M	14.54M	15.53M	17.15M	17.38M	17.55M	18.23M	18.78M	19.62M	20.58M	8.34M	8.34M	7.49M	7.33M	6.92M	6.07M	5.91M	4.43M	3.5M	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	1.69M	9.56M	11.89M	12.87M	14.01M	14.89M	15.7M	16.84M	18.54M	18.69M	18.86M	21.78M	20.28M	21.19M	22.15M	13.09M	9.91M	12.73M	12.49M	11.95M	7.57M	7.41M	7.13M	5.01M	n/a
Total Assets	20.63M	20.82M	41.97M	64.44M	86.34M	111.9M	58.83M	87.87M	116.46M	145.06M	153.04M	90.64M	104.84M	113.91M	83.15M	90.92M	111.14M	126.21M	141.93M	159.87M	175.61M	188.29M	122.31M	43.79M	n/a
Account Payables	526K	3.77M	1.51M	1.76M	1.55M	2.25M	1.76M	1.6M	2.52M	2.32M	380K	1.44M	2.73M	3.44M	1.21M	620K	1.36M	2.69M	1.38M	1.52M	2.88M	2.68M	1.37M	1.41M	n/a
Deferred Revenue	n/a	7.5M	n/a	n/a	12.48M	10.42M	7.5M	13.07M	7.5M	7.5M	7.5M	-2.14M	8.82M	7.99M	9.04M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	33.95M	46.6M	43.77M	n/a	12.27M	8.03M	3.87M	1.95M	n/a	n/a	2.66M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	1.43M	-969K	3.68M	1.62M	3.42M	1.55M	1.01M	4.36M	10.71M	9.98M	8.18M	18.39M	10.82M	10.17M	11.25M	9.12M	8.32M	7.2M	9.84M	7.72M	6.53M	4.84M	3.25M	2.43M	n/a
Total Current Liabilities	39.76M	55.54M	57.25M	12.39M	26.92M	21.44M	16.17M	17.36M	20.73M	19.8M	18.72M	19.83M	13.55M	13.61M	12.46M	9.74M	9.68M	9.89M	11.22M	9.23M	9.41M	7.52M	4.62M	3.84M	n/a
Long-Term Debt	n/a	3.88M	n/a	43.61M	36.65M	40.75M	44.77M	46.56M	46.52M	46.48M	29.26M	30.05M	29.92M	19.81M	19.72M	19.63M	19.55M	14.86M	10.46M	12.3M	14.15M	14.75M	14.72M	9.97M	n/a
Other Long-Term Liabilities	73K	7.53M	32K	659K	n/a	n/a	7.5M	n/a	7.76M	7.76M	7.76M	284K	432K	303K	169K	1.35M	1.37M	1.38M	1.38M	1.38M	1.28M	970K	1.72M	580K	n/a
Total Long-Term Liabilities	7.57M	11.4M	12.11M	57.04M	50.09M	54.81M	59.45M	61.84M	62.66M	63.17M	46.48M	40.32M	40.86M	31.09M	31.34M	20.98M	20.92M	16.23M	11.84M	13.68M	15.43M	15.72M	16.44M	10.55M	n/a
Total Liabilities	47.33M	66.94M	69.36M	69.43M	77M	76.25M	75.63M	79.2M	83.38M	82.97M	65.2M	60.15M	54.41M	44.7M	43.8M	30.72M	30.59M	26.12M	23.05M	22.92M	24.85M	23.24M	21.06M	14.38M	n/a
Total Debt	33.95M	50.48M	50.7M	51.14M	54.86M	55.34M	55.83M	56.29M	56.77M	57.22M	41.38M	40.04M	42.03M	32.58M	32.98M	19.63M	19.55M	14.86M	10.46M	12.3M	14.15M	14.75M	14.72M	9.97M	n/a
Common Stock	19K	6K	111K	111K	108K	108K	54K	54K	53K	53K	53K	47K	46K	46K	32K	32K	32K	32K	32K	32K	32K	32K	4K	20K	n/a
Retained Earnings	-588.03M	-575.67M	-554.56M	-529.22M	-505.68M	-475.12M	-444.56M	-414.69M	-386.04M	-352.31M	-320.71M	-292.52M	-263.47M	-242.55M	-221.89M	-198.85M	-176.25M	-154.62M	-133.68M	-113.38M	-97.94M	-82.08M	-66.94M	-56.41M	n/a
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-6.72M	-6.18M	n/a	-5.11M	-4.65M	-4.11M	n/a	n/a	1K	-2K	-18K	-38K	-2.68M	-2.01M	-1.43M	n/a
Shareholders Equity	-26.71M	-46.13M	-27.39M	-4.99M	9.33M	35.65M	-16.8M	8.67M	33.08M	62.09M	87.84M	30.48M	50.43M	69.21M	39.34M	60.2M	80.55M	100.09M	118.88M	136.95M	150.76M	165.05M	101.25M	29.4M	5.65K
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	4M	23.95M	54.82M	84.61M	n/a	n/a	n/a	31.07K